INFORMATION

We specialize in organizing high-quality business events, which provide only need-to-know information from leading industries’ experts.

CONTACT INFO

Email: registration@curtiswyss.com

Phone: +420 222 280 103

FOLLOW ME
Induced Proximity-Based in Drug Development
Curtis & Wyss Group is pleased to invite you to the Induced Proximity-Based in Drug Development Summit scheduled for December 16th-17th in Berlin. The upcoming B2B event brings together scientists and experts who want to discuss the new findings in the area of multispecific medicines, the potential of strategies, usage and features of small-molecule induced-proximity systems, new designing approaches, treatment methods and therapies on Induced Proximity-Based in case of drug development with the opportunity to get acquainted with the latest achievements of leaders in that trendy field.

Don't miss this opportunity to join the community of drug creation experts to dive deep into the progress of development and stay aware of the new cutting-edge strategies to develop novel therapies. We look forward to meeting you at the Induced Proximity-Based in Drug Development Summit on December 16th-17th in Berlin, Germany!

HIGHLIGHTS

Last developments in the area of the induced-proximity based in drug development

New technologies in the field of genomics, proteomics and chemoproteomics

Use of small molecule induced proximity for designing new drugs

Challenges from in-vitro to in-vivo by optimizing the design of degraders based on the structure and immersion in pharmacology in-vivo

Induced proximity and usage of small molecule protein degraders / stabilizers

Issues that are holding back discovery, including developing an analysis, defining a goal

New approaches to determine the chemical matter of proximity which contributes to the proximity mechanism of action

AUDIENCE

Pioneering academics

CTOs

CMOs

Solution Providers

Principal Scientists

R&D Pharm Leaders

Research Advisors

Drug Developers

INDUSTRIES

Pharmaceutical

Biotech

Chemically Biology

Screening Biology

Molecular Biology

Keynote Speakers
Ryan Potts

Executive Director and Head, Induced Proximity Platform at Amgen

William C. Pomerantz

Associate Professor at University of Minnesota

Markella Konstantinidou, PhD

Postdoctoral Scholar at University of California San Francisco

Binghe Wang

Regents' Professor at Georgia State University

Cristina Mayor-Ruiz

Principal Investigator at IRB Barcelona

Media Partners